Logo-ipp
Submitted: 16 Feb 2018
Accepted: 29 Mar 2018
ePublished: 02 Apr 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Immunopathol Persa. 2018;4(2): e20.
doi: 10.15171/ipp.2018.20
  Abstract View: 12205
  PDF Download: 3081

Original

The survey of effect of combination therapy with tamsulosin – finasteride compared with tamsulosin alone on symptom improvement of benign prostatic hypostatic

Ali Jabbari Sabbagh 1*, Mostafa Khalighinezhad 1

1 Department of Urology, Najafabad Azad University, School of Medicine, Isfahan, Iran
*Corresponding Author: Correspondence to Ali Jabbari Sabbagh, Email: alijabari1358@yahoo.com

Abstract

Introduction: Benign prostatic hyperplasia (BPH) is a histologic change in the prostate and one of the common diseases in middle-aged and old men. BPH, as a life-altering urinary condition requires prompt medical interventions, both medical and surgical. Alpha-1 blockers (α1-blockers) are first-line treatment for BPH. 5α-reductase inhibitors (5-ARIs), like finasteride are very effective in patients with BPH who do not respond to α1-blockers.

Objectives: This study was designed to compare the effect of tamsulosin (a selective α1- blockers) on BPH with the effect of combination therapy with tamsulosin and finasteride.

Patients and Methods: This randomized controlled clinical trial study was done in Isfahan. Around 120 men with BPH divided into 2 groups with 60 patients in each group. Both groups were evaluated with the American Urological Association (AUA) symptom score. Scoring form of AUA symptoms to determine the severity of symptoms resulting from BPH was developed by America Urological Association. Total of its scores was between 0 and 35. Then, one group received tamsulosin and the other group received combination therapy with finasteride and tamsulosin. After 4 weeks, the AUA symptom score was done for both of groups. Results were analyzed by the paired t test, t test and chi-square through SPSS version 16.

Results: No significant differences in mean of age and the AUA symptom score distribution were seen between two groups (P > 0.05). After 4 weeks of therapy, the AUA symptom score was significantly decreased in the patients who received tamsulosin and finasteride compared with the patients who received tamsulosin alone (P < 0.05).

Conclusion: The results of our study showed that tamsulosin and finasteride are effective drugs for BPH treatment. Combination therapy with finasteride and tamsulosin was significantly more effective, in our study, compared to tamsulosin alone. 


Citation: Jabbari Sabbagh A, Khalighinezhad M. The survey of effect of combination therapy with tamsulosin – finasteride compared with tamsulosin alone on symptom improvement of benign prostatic hypostatic. Immunopathol Persa. 2018;4(2):e20. DOI:10.15171/ ipp.2018.20.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 12206

Your browser does not support the canvas element.


PDF Download: 3081

Your browser does not support the canvas element.